Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.

Show other versions (1)

OBJECTIVE: To explore the cost-effectiveness of parenteral artesunate for the treatment of severe malaria in children and its potential impact on hospital budgets. METHODS: The costs of inpatient care of children with severe malaria were assessed in four of the 11 sites included in the African Quini...

Full description

Bibliographic Details
Main Authors:	Lubell, Y, Riewpaiboon, A, Dondorp, A, von Seidlein, L, Mokuolu, O, Nansumba, M, Gesase, S, Kent, A, Mtove, G, Olaosebikan, R, Ngum, W, Fanello, C, Hendriksen, I, Day, N, White, N, Yeung, S
Format:	Journal article
Language:	English
Published:	2011

Similar Items

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-saharan Africa
by: Lubell, Y, et al.
Published: (2011)

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa
by: Yoel Lubell, et al.
Published: (2011-07-01)

Population pharmacokinetics of intramuscular artesunate in african children with severe malaria: Implications for a practical dosing regimen
by: Hendriksen, I, et al.
Published: (2013)

Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.
by: Hendriksen, I, et al.
Published: (2013)

Artesunate for severe malaria in African children Reply
by: Dondorp, A, et al.
Published: (2011)

Artesunate for severe malaria in African children - Authors' reply
by: Dondorp, A, et al.
Published: (2011)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
by: Dondorp, A, et al.
Published: (2010)

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): An open-label, randomised trial
by: Dondorp, A, et al.
Published: (2010)

Artesunate dosing in severe falciparum malaria.
by: Dondorp, A, et al.
Published: (2012)

Cost-effectiveness of artesunate for the treatment of severe malaria.
by: Lubell, Y, et al.
Published: (2009)

A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria.
by: Newton, P, et al.
Published: (2001)

Artesunate versus quinine for severe falciparum malaria - Reply
by: White, N, et al.
Published: (2006)

Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.
by: Hendriksen, I, et al.
Published: (2013)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
by: Tarning, J, et al.
Published: (2024)

An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
by: Saralamba, S, et al.
Published: (2023)

Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.
by: Hendriksen, I, et al.
Published: (2012)

Evaluation of a PfHRP2 and a pLDH-based rapid diagnostic test for the diagnosis of severe malaria in 2 populations of African children.
by: Hendriksen, I, et al.
Published: (2011)

Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
by: Joel Tarning, et al.
Published: (2024-10-01)

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
by: Dondorp, A, et al.
Published: (2005)

Stopping prereferral rectal artesunate - a grave error
by: Watson, JA, et al.
Published: (2022)

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine
by: Fanello, C, et al.
Published: (2017)

Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria.
by: Ramutton, T, et al.
Published: (2012)

Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.
by: von Seidlein, L, et al.
Published: (2012)

Stopping prereferral rectal artesunate — a grave error
by: Arjen M Dondorp, et al.
Published: (2022-07-01)

Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine
by: C. Fanello, et al.
Published: (2017-08-01)

Validation and application of a liquid chromatographic-mass spectrometric method for determination of artesunate in pharmaceutical samples.
by: Lindegårdh, N, et al.
Published: (2007)

Counterfeit artesunate antimalarials in southeast Asia.
by: Newton, P, et al.
Published: (2003)

Plasma Concentration of Parasite DNA as a Measure of Disease Severity in Falciparum Malaria.
by: Imwong, M, et al.
Published: (2014)

Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration.
by: Hendriksen, I, et al.
Published: (2013)

Defining falciparum-malaria-attributable severe febrile illness in moderate-to-high transmission settings on the basis of plasma PfHRP2 concentration
by: Hendriksen, I, et al.
Published: (2012)

Extended haematological follow-up after parenteral artesunate in African children with severe malaria
by: Rolling Thierry, et al.
Published: (2012-10-01)

Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria?
by: Maude, R, et al.
Published: (2009)

HYPOTHESES OF DRUG RESPONSE DYNAMICS TO EXPLAIN RECRUDESCENCE IN ARTESUNATE RESISTANT PLASMODIUM FALCIPARUM MALARIA
by: Maude, R, et al.
Published: (2009)

RECTAL AND INTRAVENOUS ARTESUNATE FOR SEVERE MALARIA: MODELLING THE IMPACT OF ARTEMISININ RESISTANCE
by: Maude, R, et al.
Published: (2010)

Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa
by: Fanello, C, et al.
Published: (2021)

Misattribution of central nervous system dysfunction to artesunate.
by: Newton, P, et al.
Published: (2005)

Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.
by: Ilse C E Hendriksen, et al.
Published: (2012-01-01)

Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
by: Newton, P, et al.
Published: (2003)

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma.
by: Hanpithakpong, W, et al.
Published: (2008)

Malaria
by: White, N, et al.
Published: (2014)